Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Varian Medical Systems Inc reaffirms FY 2014 guidance; gives Q2 2014 guidance below analysts' estimates


Wednesday, 22 Jan 2014 04:05pm EST 

Varian Medical Systems Inc:Continues to expect FY 2014 total company revenues could increase by about 6 to 8 percent over FY 2013.Net earnings per diluted share for the FY 2014 could be in the range of $4.22 to $4.34.Expects total company revenues for Q2 2014 to be about equal to Q2 2013 when proton revenues were high.Net earnings per diluted share for Q2 2014 could be in the range of $1.00 to $1.04.The company reported revenue of $2.943 bln in FY 2013.The company reported revenue of $768 mln in Q2 2013.FY 2014 revenues of $3.139 bln and EPS of $4.34 - Thomson Reuters I/B/E/S.Q2 2014 revenues of $808 mln and EPS of $1.10 - Thomson Reuters I/B/E/S. 

Company Quote

87.58
2.07 +2.42%
23 Jul 2014